# Primary Prophylaxis for Variceal Bleed in Biliary Atresia

> **NCT04494763** · NA · UNKNOWN · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 92 (estimated)

## Conditions studied

- Portal Hypertension, Biliary Atresia

## Interventions

- **DRUG:** Propanolol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04494763
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-15
- **Primary completion:** 2022-06-13
- **Final completion:** 2022-06-15
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2021-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04494763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04494763, "Primary Prophylaxis for Variceal Bleed in Biliary Atresia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04494763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*